Safety and Efficacy of 2910 nm Fiber Laser Resurfacing and Laser-Coring
NCT: NCT07254884 · ACTIVE_NOT_RECRUITING
Brief Summary
The primary objective of this clinical trial is to evaluate the safety and effectiveness of the 2,910 nm mid-infrared erbium-doped fluoride fiber glass laser (UltraClear, Acclaro Medical) for non-invasive dermatological aesthetic treatment of three facial regions: eyebrow lift (Region 1), submental tissue lift (Region 2), and improvement of rhytids and skin laxity in the cheeks, midface, and jawline (Region 3).
Frequently Asked Questions
What is Safety and Efficacy of 2910 nm Fiber Laser Resurfacing and Laser-Coring?
Safety and Efficacy of 2910 nm Fiber Laser Resurfacing and Laser-Coring is a clinical trial registered under NCT07254884. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07254884?
The current status of NCT07254884 (Safety and Efficacy of 2910 nm Fiber Laser Resurfacing and Laser-Coring) is: ACTIVE_NOT_RECRUITING.
When did Safety and Efficacy of 2910 nm Fiber Laser Resurfacing and Laser-Coring start?
Safety and Efficacy of 2910 nm Fiber Laser Resurfacing and Laser-Coring started on 2025-11-24.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.